Showing results (61-70 of 183) with videos related to
Sort By:
Pageof 19
The Oncologist|May 30, 2014
Safety profile of Pertuzumab with Trastuzumab and Docetaxel in patients from Asia with human epidermal growth factor receptor 2-positive metastatic breast cancer: results from the phase III trial CLEOPATRASandra M Swain, Young-Hyuck Im, Seock-Ah Im, et al.Journal of Oncology Practice|August 15, 2013
ASCO's approach to a learning health care system in oncologyGeorge W Sledge, Clifford A Hudis, Sandra M Swain, et al.Oncology|July 28, 2007
A novel case of bisphosphonate-related osteonecrosis of the torus palatinus in a patient with metastatic breast cancerMatthew L Goldman, Neelima Denduluri, Arlene W Berman, et al.JCO Oncology Practice|May 11, 2023
Real-World First-Line Use of Pertuzumab With Different Taxanes for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Comparative Effectiveness Study Using US Electronic Health RecordsLetizia Polito, Jinjoo Shim, Sara A Hurvitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2024
Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data AvailabilityNatansh D Modi, Sandra M Swain, Marc Buyse, et al.Clinical Breast Cancer|June 15, 2012
Evaluation of lymphangiogenic factors, vascular endothelial growth factor D and E-cadherin in distinguishing inflammatory from locally advanced breast cancerPaul H Levine, Chia C Portera, Heather J Hoffman, et al.Journal of Oncology Practice|February 19, 2015
Improving Documentation of Pain Management at MedStar Washington Cancer InstituteVishal Ranpura, Sundeep Agrawal, Puja Chokshi, et al.Breast Cancer Research and Treatment|February 28, 2008
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trialSandra M Swain, Stephanie R Land, Marcie W Ritter, et al.The Journal of Clinical Investigation|January 4, 2003
Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cellsKip A West, John Brognard, Amy S Clark, et al.The Oncologist|March 12, 2013
Cardiac tolerability of pertuzumab plus trastuzumab plus docetaxel in patients with HER2-positive metastatic breast cancer in CLEOPATRA: a randomized, double-blind, placebo-controlled phase III studySandra M Swain, Michael S Ewer, Javier Cortés, et al.Pageof 19